Blog / Archives
Medical Science News Ramping Up for ASCO
A bull market in life science stocks has revved up news for the upcoming ASCO Meeting on June 3 in Chicago. We will provide limited coverage of stocks to watch and scientific articles of interest....
Personalized Healthcare Gets a Boost from Nestle/Prometheus Deal
The Life Science market consolidation trend continued today as Nestle SA acquires privately held Prometheus Laboratories, Inc. of San Diego,CA for about $567M according to a Bloomberg story...
The Red Screen is the Winner Today But Cubist (CBST) Is Up On Buyout Rumors
It was a nasty day from the beginning but losses abated as the day wore on. The NASDAQ was off 1.68%, the Dow down 1.05% and the S&P down 1.15% to 1317. The S&P held trend lines in the...
ASCO June 3-7 Chicago: Rally Today
The pre-ASCO hype has already begun but many biopharma stocks have already run up 15%+ YTD. So it is time to be cautious as there may be an "ASCO Effect"- a sell on the news effect. Despite a weak...
Rayno Life Science Portfolio Winners Today: ABAX,CBST,CSII,NEOG
M&A Premium Rocks On In a flat life science market eclipsed by the LinkedIn (LNKD) IPO and its day trading frenzy, many life science stocks in the Rayno Life Science Portfolio logged decent...
GenProbe (GPRO) Sells Off After ThermoFisher (TMO) Announces Phadia Buyout
But ThermoFisher (TMO $65.12) is Up 3.78% on Volume of 3.2M Shares GenProbe (GPRO $84.10) down 2.9% sold off some of of the speculative gains from yesterday after ThermoFisherScientific (TMO)...
GenProbe (GPRO) up 8%+on Buy-Out Rumors
Speculation chat is driving up shares of GenProbe (GPRO) on heavier volume of 2.5M shares. Two stories are notable one from the Wall Street Journal on ThermoFisher (TMO) a potential bidder, but also...
Metrics of Pure Play Diagnostic Companies: Comparison to GenProbe
M&A Premium of Diagnostic Companies Bloomberg reported on April 29 that GenProbe (GPRO) was seeking a buyer. We reported earlier this month on the M&A trend in biotechnology, tools and...
Big Sell-Off in Oil, Gas and Other Commodities Spooks the Market
Relative Safety in Healthcare Stocks Today's sell-off in the energy complex with the back-drop of a U.S. slow growth scenario plus the Euro being vulnerable due to Greece and Ireland has spooked the...
Life Science Stocks Capture M&A Premium
Deals Are Bullish for the Market Yesterday's Alkermes (ALKS) deal with Elan (ELN) supports the major M&A trend in the life science market. Timing is everything in a hot market. The rationale for...